Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN66,9266,98-0,30
Msft-2,45
Nokia3,3843,43-0,69
IBM-8,25
Mercedes-Benz Group AG73,1473,16-1,08
PFE-3,84
26.04.2024 7:30:49
Indexy online
AD Index online
select
AD Index online
 

Carl Zeiss Medi
Poslední obchod Změna (%) Změna Objem obchodů ()
- - -
Poslední obchod Změna (%) Změna Objem obchodů ()
- - -
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 26.04.2024
Popis společnosti
Obecné informace
Název společnostiCarl Zeiss Meditec AG
TickerAFX
Kmenové akcie:Ordinary Shares
RICAFXG.DE
ISINDE0005313704
Poslední známé roční výsledky30.09.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 30.09.2023 4 823
Akcie v oběhu k 30.09.2023 89 440 570
MěnaEUR
Kontaktní informace
UliceGoeschwitzer Strasse 51-52
MěstoJENA
PSČ07745
ZeměGermany
Kontatní osobaSebastian Frericks
Funkce kontaktní osobyInvestor Relations Director
Telefon493 641 220 331
Fax493641220117
Kontatní telefon493 641 220 116

Business Summary: Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
Financial Summary: BRIEF: For the three months ended 31 December 2023, Carl Zeiss Meditec AG revenues increased 1% to EUR475M. Net income applicable to common stockholders decreased 27% to EUR37.4M. Revenues reflect Microsurgery segment increase of 11% to EUR123.9M, EMEA segment increase of 28% to EUR156.5M. Net income was offset by Research and development expenses increase of 8% to EUR87.8M (expense).
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Advanced Medical Equipment & Technology (NEC)
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSCommercial and Service Industry Machinery Manufacturing
NAICSAnalytical Laboratory Instrument Manufacturing
NAICSOphthalmic Goods Manufacturing
NAICSSoftware Publishers
NAICSComputer Systems Design Services
NAICSComputing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
NAICS2007Electromedical Apparatus Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Optical Instrument & Lens Mfg
NAICS2007Analytical Laboratory Instrument Mfg
NAICS2007Ophthalmic Goods Mfg
NAICS2007Software Publishers
NAICS2007Computer Systems Design Services
NAICS2007Data Processing, Hosting, and Related Services
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Optical Instrument and Lens Manufacturing
NAICS1997Analytical Laboratory Instrument Manufacturing
NAICS1997Ophthalmic Goods Manufacturing
NAICS1997Software Publishers
NAICS1997Computer Systems Design Services
NAICS1997Data Processing Services
SICElectromedical Equipment
SICSurgical And Medical Instruments
SICService Industry MacHinery, Nec
SICAnalytical Instruments
SICOphthalmic Goods
SICPrepackaged Software
SICComputer Integrated System Design
SICData Processing And Preparation



  • Poslední aktualizace: 26.04.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman of the Supervisory BoardKarl Lamprecht5927.05.202127.05.2021
Chairman of the Management Board, President, Chief Executive OfficerMarkus Weber5001.01.202201.01.2022
Deputy Chairman of the Supervisory Board - Employee RepresentativeRene Denner4322.03.202322.03.2023
Chief Financial Officer, Member of the Management BoardJustus Wehmer5801.10.201801.10.2018